118 related articles for article (PubMed ID: 6236801)
1. Autoimmune response directed to pancreatic beta cells in rats induced by combined treatment with low doses of streptozotocin and complete Freund's adjuvant.
Ziegler M; Ziegler B; Hehmke B; Dietz H; Hildmann W; Kauert C
Biomed Biochim Acta; 1984; 43(5):675-81. PubMed ID: 6236801
[TBL] [Abstract][Full Text] [Related]
2. Genetic control of diabetes induction by complete Freund's adjuvant combined with subdiabetogenic doses of streptozotocin in Lewis rats--evidence for transient cytotoxicity against beta cells.
Ziegler B; Tietz S; Kohnert KD; Köhler E; Knospe S; Klöting I; Ziegler M
Exp Clin Endocrinol; 1987 Aug; 89(3):269-75. PubMed ID: 2959492
[TBL] [Abstract][Full Text] [Related]
3. Destruction of pancreatic beta cells in rats by complete Freund's adjuvant combined with non-diabetogenic doses of streptozotocin.
Kohnert KD; Odselius R; Fält K; Ziegler B; Ziegler M; Falkmer S
Diabetes Res; 1987 May; 5(1):1-11. PubMed ID: 2957141
[TBL] [Abstract][Full Text] [Related]
4. Genetic control of susceptibility to severe hyperglycaemia evoked by CFA/SZ-induced immune response against beta cells in various rat strains.
Ziegler M; Ziegler B; Kohnert KD; Klöting I
Biomed Biochim Acta; 1988; 47(4-5):337-42. PubMed ID: 2977097
[TBL] [Abstract][Full Text] [Related]
5. Survival of islet isografts despite cytotoxicity against pancreatic islets measured in vitro.
Ziegler B; Köhler E; Klöting I; Besch W; Ziegler M
Exp Clin Endocrinol; 1990 Feb; 95(1):31-8. PubMed ID: 2139850
[TBL] [Abstract][Full Text] [Related]
6. Histopathological lesions in the pancreas of a rat model of diabetes induced with complete Freund's adjuvant and low-dose streptozotocin.
Kohnert KD; Fält K; Ziegler B; Odselius R; Ziegler M; Falkmer S
Exp Clin Endocrinol; 1990 Feb; 95(1):47-56. PubMed ID: 2139852
[TBL] [Abstract][Full Text] [Related]
7. Severe hyperglycaemia caused by autoimmunization to beta cells in rats.
Ziegler M; Ziegler B; Hehmke B
Diabetologia; 1984 Jul; 27 Suppl():163-5. PubMed ID: 6237014
[TBL] [Abstract][Full Text] [Related]
8. Biochemical, immunohistochemical and ultrastructural studies of the alteration of pancreatic beta cells resulting from the combined effects of complete Freund's adjuvant and non-diabetogenic doses of streptozotocin.
Kohnert KD; Ziegler B; Fält K; Odselius R; Ziegler M; Falkmer S
Exp Clin Endocrinol; 1987 Aug; 89(3):259-68. PubMed ID: 2959491
[TBL] [Abstract][Full Text] [Related]
9. Silica prevents the induction of diabetes with complete Freund's adjuvant and low-dose streptozotocin in rats.
Wright JR; Lacy PE
Diabetes Res; 1989 Jun; 11(2):51-4. PubMed ID: 2559826
[TBL] [Abstract][Full Text] [Related]
10. Subcutaneous cyclosporin prevents the development of complete Freund's adjuvant-streptozotocin-induced diabetes in the rat.
Hernandez R; Torres MD; Campillo JE
Diabete Metab; 1991; 17(2):281-5. PubMed ID: 1830858
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor mediates the protective effect of Freund's adjuvant against autoimmune diabetes in BB rats.
Rabinovitch A; Suarez-Pinzon WL; Lapchak PH; Meager A; Power RF
J Autoimmun; 1995 Jun; 8(3):357-66. PubMed ID: 7575997
[TBL] [Abstract][Full Text] [Related]
12. The possibility that pancreatic beta cell destruction leading to type 1 diabetes is initiated by the release of cytokines by polyclonal activation of the immune system.
Ziegler M; Ziegler B
Exp Clin Endocrinol; 1990 Feb; 95(1):110-8. PubMed ID: 2139848
[TBL] [Abstract][Full Text] [Related]
13. Study on pancreatic lymphatics in nonobese diabetic mouse with prevention of insulitis and diabetes by adjuvant immunotherapy.
Qu P; Ji RC; Shimoda H; Miura M; Kato S
Anat Rec A Discov Mol Cell Evol Biol; 2004 Dec; 281(2):1326-36. PubMed ID: 15386276
[TBL] [Abstract][Full Text] [Related]
14. Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice.
Qin HY; Sadelain MW; Hitchon C; Lauzon J; Singh B
J Immunol; 1993 Mar; 150(5):2072-80. PubMed ID: 8436836
[TBL] [Abstract][Full Text] [Related]
15. [Study on the prevention of insulitis and diabetes by complete Freund's adjuvant in NOD female mice].
Yang Z; Wu H; Zhou Z; Liao EY; Yang W
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(5):411-4. PubMed ID: 12080669
[TBL] [Abstract][Full Text] [Related]
16. Development of cytotoxic islet cell antibodies in rats following damage of the pancreas by complete Freund's adjuvant combined with a nondiabetogenic dose of streptozotocin.
Kohnert KD; Ziegler B; Hehmke B; Fält K; Odselius R; Ziegler M
Int J Pancreatol; 1990 Jan; 6(1):33-48. PubMed ID: 2146330
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effects of adjuvants, endotoxin, and fasting on induction of diabetes with multiple low doses of streptozocin in rats.
Wright JR; Lacy PE
Diabetes; 1988 Jan; 37(1):112-8. PubMed ID: 2961641
[TBL] [Abstract][Full Text] [Related]
18. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
19. Detection of antibodies to islet cell and splenic lymphocytes in diabetes-prone BB and adjuvant-streptozotocin treated Lewis rats by ELISA and immunoblot analysis.
Kohnert KD; Besch W; Schröder D; Ziegler B; Hehmke B; Fält K; Ziegler M
Allerg Immunol (Leipz); 1990; 36(4):321-31. PubMed ID: 2097900
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulation of low dose streptozocin diabetes in mice reveals that insulitis is not obligatory for B cell destruction.
Papaccio G; Chieffi Baccari G; Esposito V
J Anat; 1992 Dec; 181 ( Pt 3)(Pt 3):403-7. PubMed ID: 1304577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
